FOR IMMEDIATE RELEASE

NOTICE OF PALADIN LABS INC. CONFERENCE CALL

Montreal, Canada, May 7, 2002 - Paladin Labs Inc. (TSE:PLB) today announced that the Company will host a conference call to discuss its first quarter results on Thursday, May 9, 2002, at 4:30 p.m. EST. Paladin cordially invites all interested parties to participate in this call.

DATE:	Thursday, May 9, 2002
TIME:	4:30 p.m. EST
DIAL IN NUMBER:	1-800-478-9326 or 1-416-695-5801
REFERENCE NUMBER:	1159946
TAPED REPLAY:	1-800-408-3053 OR 1-416-695-5800 Available from Thursday, May 9th at 6:30 p.m. until Thursday, May 16th at midnight.

The call will be hosted by Mr. Jonathan Ross Goodman, President and CEO, and will be followed by a question and answer session. The Company looks forward to your participation.

The call will also be audio-cast live and archived for 90 days at www.paladinlabs.com and and www.financialdisclosure.ca.

About Paladin Labs Inc.
Paladin Labs, headquartered in Montreal, Quebec, is a rapidly growing pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's most profitable publicly-traded pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Paladin Web Site at www.paladinlabs.com

For further information please contact:

Paladin Labs Inc.
Samira Sakhia, Chief Financial Officer
Tel: 514-340-5067
e-mail: info@paladin-labs.com
Web Site: www.paladinlabs.com

The Equicom Group Inc.
Joanna Longo
Investor Relations
Tel: 416-815-0700 ext.233
e-mail: jlongo@equicomgroup.com